The idea that MMF should be used irrespective of histology has called into question the need for biopsy. Given the uncertainties of the pathogenesis of lupus nephritis, the need to correlate ...

Following his medical training in Pathology and Rheumatology at the National University of Singapore and ... and genetic players leading to murine lupus nephritis, with corresponding translational ...

Fibroblast activating protein inhibitor (FAPI) PET/CT imaging may be a non-invasive modality to monitor IgA nephropathy (IgAN) progression, preliminary study results suggest.

The FDA is expected to make a decision on approval by October 2025. “In people with lupus nephritis, Gazyva demonstrated a complete renal response benefit, a meaningful clinical outcome linked ...